Company Profile

Niowave Inc
Profile last edited on: 1/4/22      CAGE: 4FV39      UEI: WJLJSN2AT8P1

Business Identifier: Medical and industrial radioisotopes from uranium and radium
Year Founded
2005
First Award
2007
Latest Award
2020
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1012 North Walnut Street
Lansing, MI 48906
   (517) 999-3475
   info@niowaveinc.com
   www.niowaveinc.com
Location: Single
Congr. District: 08
County: 

Public Profile

Niowave was originally esablished with the objective of commercializing superconducting electron linear accelerators in a diversity of applications from healthcare to national security. Very active in the SBIR-STTR arena since soon after its founding, the firm has matured to become a lead player in superconducting accelerator research. In 2008, the firm had qualified as the second US vendor for accelerating cavities for the International Linear Collider and, in 2009, the first private company to design, fabricate, and test a superconducting electron injector. Now the firm is a domestic supplier of medical and industrial radioisotopes from uranium fission and stable targets. Isotope inventories available for purchase include alpha, beta, and gamma sources. The Niowave system uses a superconducting linac instead of a nuclear reactor which is simpler to operate and less costly to license. It also eliminates the need for a nuclear reactor and weapons grade uranium (HEU). The small batch radiochemistry operations can be automated, and do not require licensing as a nuclear reprocessing facility.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
100-149
Revenue Range
10M-15M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Key People / Management

  Terry L Grimm -- President, Founder and Senior Scientist

  Chase Boulware

  Chase H Boulware

  Matt Burba -- Chief Operating Officer

  Jean Delayen

  Dmitry Gorelov

  Lee Grimm -- Chairman of the Board

  William Peters

  Valeriia Starovoitova